Janus Henderson Group
EPZM

Janus Henderson Group’s Epizyme, Inc EPZM Stock Holding History

Janus Henderson Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,541
Closed -$17K – 2734
2022
Q1 		$17K Buy
14,541
+12
+0.1% +$20 ﹤0.01% 2637
2021
Q4 		$36K Buy
+14,529
New +$57.1K ﹤0.01% 2543
2020
Q3 		– Sell
-1,994,235
Closed -$32M – 1385
2020
Q2 		$32M Buy
1,994,235
+46,404
+2% +$810K 0.02% 598
2020
Q1 		$30.2M Buy
1,947,831
+1,383,330
+245% +$29.7M 0.02% 580
2019
Q4 		$13.9M Buy
+564,501
New +$8.38M 0.01% 906

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group's EPZM Position: Q2 2022 in Review

Janus Henderson Group sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 14,541 shares — an estimated $17K sold.

Janus Henderson Group first reported a position in EPZM in Q4 2019 and held it in 5 quarters. The position peaked at $32M in Q2 2020. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Janus Henderson Group reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Janus Henderson Group sold 14,541 Epizyme, Inc shares in Q2 2022, an estimated $17K.
  • Janus Henderson Group first reported a position in Epizyme, Inc in Q4 2019 and held it in 5 quarters.
  • Janus Henderson Group's Epizyme, Inc position peaked at $32M in Q2 2020.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Janus Henderson Group's 13F filing for Q2 2022, filed 15 Aug 2022.